[1]Lacroix A,Feelders RA,Stratakis CA,et al.Cushing’s syndrome [J].TheLancet,2015,386(9996):913-927.
[2]Loriaux DL.Diagnosis and differential diagnosis of cushing’s syndrome[J].N Engl J Med,2017,376(15):1451-1459.
[3]Mancini T,Doga M,Mazziotti G,et al.Cushing’s syndrome and bone [J].Pituitary,2004,7(4):249-252.
[4]Canalis E,Bilezikian JP,Angeli A,et al.Perspectives on glucocorticoidinduced osteoporosis[J].Bone,2004,34(4):593-598.
[5]Seibel MJ,Cooper MS,Zhou H.Glucocorticoid-induced osteoporosis:mechanisms,management,and future perspectives[J].Lancet Diabetes Endocrinol,2013,1(1):59-70.
[6]Jung HS,Jee WH,McCauley TR,et al.Discrimination of metastatic from acute osteoporotic compression spinal fractures with MR imaging[J].Radiographics,2003,23(1):179-187.
[7]Van Staa TP,Laan RF,Barton IP,et al.Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy[J].Arthritis Rheum,2003,48(11):3224-3229.
[8]Cicala D,Briganti F,Casale L,et al.Atraumatic vertebral compression fractures:differential diagnosis between benign osteoporotic and malignant fractures by MRI[J].Musculoskelet Surg,2013,97(Suppl 2):S169-179.
[9]Faggiano A,Pivonello R,Filippella M,et al.Spine abnormalities and damage in patients cured from Cushing’s disease[J].Pituitary 2001,4(3):153-161.
[10]Di Somma C,Colao A,Pivonello R,et al.Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing’s disease[J].Clin Endocrinol,1998,48(5):655-662.
[11]Klazen CA,Venmans A,de Vries J,et al.Percutaneous vertebroplasty is not a risk factor for new osteoporotic compression fractures:results from VERTOS Ⅱ[J].AJNR American journal of neuroradiology,2010,31(8):1447-1450.
[12]Manning PJ,Evans MC,Reid IR.Normal bone mineral density following cure of Cushing’s syndrome[J].Clin Endocrinol,1992,36(3):229-234.